Shares of CRH Medical Corp (NYSEAMERICAN:CRHM) have received a consensus recommendation of “Buy” from the nine ratings firms that are covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $4.00.
Separately, Zacks Investment Research raised CRH Medical from a “hold” rating to a “buy” rating and set a $3.00 price target for the company in a report on Monday, January 8th.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Pacific Ridge Capital Partners LLC boosted its position in shares of CRH Medical by 69.9% during the fourth quarter. Pacific Ridge Capital Partners LLC now owns 2,163,944 shares of the company’s stock worth $5,734,000 after buying an additional 890,300 shares during the period. Stifel Financial Corp boosted its position in shares of CRH Medical by 7.7% during the third quarter. Stifel Financial Corp now owns 1,665,839 shares of the company’s stock worth $4,332,000 after buying an additional 119,685 shares during the period. JPMorgan Chase & Co. boosted its position in shares of CRH Medical by 69.1% during the third quarter. JPMorgan Chase & Co. now owns 410,100 shares of the company’s stock worth $964,000 after buying an additional 167,600 shares during the period. Baird Financial Group Inc. purchased a new position in shares of CRH Medical during the fourth quarter worth $301,000. Finally, TD Asset Management Inc. boosted its position in shares of CRH Medical by 65.3% during the third quarter. TD Asset Management Inc. now owns 111,054 shares of the company’s stock worth $289,000 after buying an additional 43,851 shares during the period.
CRHM stock remained flat at $$2.70 during mid-day trading on Friday. The company’s stock had a trading volume of 1,403 shares, compared to its average volume of 99,824. CRH Medical has a 52 week low of $1.46 and a 52 week high of $9.10.
CRH Medical (NYSEAMERICAN:CRHM) last released its earnings results on Monday, March 5th. The company reported $0.04 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.01. The firm had revenue of $32.30 million during the quarter, compared to analysts’ expectations of $27.35 million.
COPYRIGHT VIOLATION WARNING: This story was originally posted by Macon Daily and is owned by of Macon Daily. If you are viewing this story on another domain, it was stolen and republished in violation of US and international trademark and copyright law. The original version of this story can be accessed at https://macondaily.com/2018/04/20/crh-medical-corp-crhm-receives-consensus-recommendation-of-buy-from-analysts.html.
About CRH Medical
CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.